In Brief: Incstar
This article was originally published in The Gray Sheet
Executive Summary
Incstar: Receives 510(k) clearance for a first generation complement activation enzyme (CAE) assay used to provide "general information about the immune system in certain disease states," including systemic lupus erythematosus, rheumatic disorders, "certain rare connective tissue disorders and massive tissue injury." The Stillwater, Minnesota-based immunodiagnostics firm says its CAE kit offers: "one year stability compared to two weeks" with competitors' products, the capability of performing large volume testing "in less than three hours," and reduced "hands on time in assay performance"...
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.